These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 1666185)
1. A structure function study of C-terminal extensions of bombesin. Mervic M; Moody TW; Komoriya A Peptides; 1991; 12(5):1149-51. PubMed ID: 1666185 [TBL] [Abstract][Full Text] [Related]
2. [Des-Met14]bombesin analogues function as small cell lung cancer bombesin receptor antagonists. Staley J; Coy D; Taylor JE; Kim S; Moody TW Peptides; 1991; 12(1):145-9. PubMed ID: 1646997 [TBL] [Abstract][Full Text] [Related]
3. Small cell lung cancer bombesin receptors are antagonized by reduced peptide bond analogues. Mahmoud S; Palaszynski E; Fiskum G; Coy DH; Moody TW Life Sci; 1989; 44(5):367-73. PubMed ID: 2536883 [TBL] [Abstract][Full Text] [Related]
4. [Psi 13,14] bombesin analogues inhibit growth of small cell lung cancerin vitro and in vivo. Mahmoud S; Staley J; Taylor J; Bogden A; Moreau JP; Coy D; Avis I; Cuttitta F; Mulshine JL; Moody TW Cancer Res; 1991 Apr; 51(7):1798-802. PubMed ID: 1848479 [TBL] [Abstract][Full Text] [Related]
5. des-Met carboxyl-terminally modified analogues of bombesin function as potent bombesin receptor antagonists, partial agonists, or agonists. Wang LH; Coy DH; Taylor JE; Jiang NY; Moreau JP; Huang SC; Frucht H; Haffar BM; Jensen RT J Biol Chem; 1990 Sep; 265(26):15695-703. PubMed ID: 1697594 [TBL] [Abstract][Full Text] [Related]
6. The release of bombesin-like peptides from small cell lung cancer cells. Moody TW; Korman LY Ann N Y Acad Sci; 1988; 547():351-9. PubMed ID: 2853597 [TBL] [Abstract][Full Text] [Related]
7. Short-chain pseudopeptide bombesin receptor antagonists with enhanced binding affinities for pancreatic acinar and Swiss 3T3 cells display strong antimitotic activity. Coy DH; Taylor JE; Jiang NY; Kim SH; Wang LH; Huang SC; Moreau JP; Gardner JD; Jensen RT J Biol Chem; 1989 Sep; 264(25):14691-7. PubMed ID: 2475489 [TBL] [Abstract][Full Text] [Related]
8. (D-Phe12) bombesin and substance P analogues function as central bombesin receptor antagonists. Merali Z; Merchant CA; Crawley JN; Coy DH; Heinz-Erian P; Jensen RT; Moody TW Synapse; 1988; 2(3):282-7. PubMed ID: 2463692 [TBL] [Abstract][Full Text] [Related]
9. Potent bombesin receptor antagonists distinguish receptor subtypes. von Schrenck T; Wang LH; Coy DH; Villanueva ML; Mantey S; Jensen RT Am J Physiol; 1990 Sep; 259(3 Pt 1):G468-73. PubMed ID: 2169207 [TBL] [Abstract][Full Text] [Related]
10. Neuromedin B binds with high affinity, elevates cytosolic calcium and stimulates the growth of small-cell lung cancer cell lines. Moody TW; Staley J; Zia F; Coy DH; Jensen RT J Pharmacol Exp Ther; 1992 Oct; 263(1):311-7. PubMed ID: 1328611 [TBL] [Abstract][Full Text] [Related]
11. Potent bombesin antagonists with C-terminal Leu-psi(CH2-N)-Tac-NH2 or its derivatives. Cai RZ; Reile H; Armatis P; Schally AV Proc Natl Acad Sci U S A; 1994 Dec; 91(26):12664-8. PubMed ID: 7809097 [TBL] [Abstract][Full Text] [Related]
12. Activation of neuromedin B-preferring bombesin receptors on rat glioblastoma C-6 cells increases cellular Ca2+ and phosphoinositides. Wang LH; Battey JF; Wada E; Lin JT; Mantey S; Coy DH; Jensen RT Biochem J; 1992 Sep; 286 ( Pt 2)(Pt 2):641-8. PubMed ID: 1326946 [TBL] [Abstract][Full Text] [Related]
13. Biological effects and receptor binding affinities of new pseudononapeptide bombesin/GRP receptor antagonists with N-terminal D-Trp or D-Tpi. Radulovic S; Cai RZ; Serfozo P; Groot K; Redding TW; Pinski J; Schally AV Int J Pept Protein Res; 1991 Dec; 38(6):593-600. PubMed ID: 1726427 [TBL] [Abstract][Full Text] [Related]
14. BW2258U89: a GRP receptor antagonist which inhibits small cell lung cancer growth. Moody TW; Venugopal R; Zia F; Patierno S; Leban JJ; McDermed J Life Sci; 1995; 56(7):521-9. PubMed ID: 7869832 [TBL] [Abstract][Full Text] [Related]
15. Human glioblastoma cell lines have neuropeptide receptors for bombesin/gastrin-releasing peptide. Moody TW; Mahmoud S; Staley J; Naldini L; Cirillo D; South V; Felder S; Kris R J Mol Neurosci; 1989; 1(4):235-42. PubMed ID: 2561955 [TBL] [Abstract][Full Text] [Related]
16. Desmethionine alkylamide bombesin analogues: a new class of bombesin receptor antagonists with potent antisecretory activity in pancreatic acini and antimitotic activity in Swiss 3T3 cells. Wang LH; Coy DH; Taylor JE; Jiang NY; Kim SH; Moreau JP; Huang SC; Mantey SA; Frucht H; Jensen RT Biochemistry; 1990 Jan; 29(3):616-22. PubMed ID: 1692477 [TBL] [Abstract][Full Text] [Related]
17. Antitumoral activity of bombesin analogues on small cell lung cancer xenografts: relationship with bombesin receptor expression. Thomas F; Arvelo F; Antoine E; Jacrot M; Poupon MF Cancer Res; 1992 Sep; 52(18):4872-7. PubMed ID: 1325285 [TBL] [Abstract][Full Text] [Related]
18. Metabolic stability and tumor inhibition of bombesin/GRP receptor antagonists. Davis TP; Crowell S; Taylor J; Clark DL; Coy D; Staley J; Moody TW Peptides; 1992; 13(2):401-7. PubMed ID: 1329046 [TBL] [Abstract][Full Text] [Related]
19. High affinity receptors for bombesin/GRP-like peptides on human small cell lung cancer. Moody TW; Carney DN; Cuttitta F; Quattrocchi K; Minna JD Life Sci; 1985 Jul; 37(2):105-13. PubMed ID: 2409423 [TBL] [Abstract][Full Text] [Related]
20. Reduction in receptors for bombesin and epidermal growth factor in xenografts of human small-cell lung cancer after treatment with bombesin antagonist RC-3095. Halmos G; Schally AV Proc Natl Acad Sci U S A; 1997 Feb; 94(3):956-60. PubMed ID: 9023364 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]